Literature DB >> 1275989

A comparison of cardiovascular effects of dobutamine and isoprenaline after open heart surgery.

F Kersting, F Follath, R Moulds, J Mucklow, R McCloy, J Sheares, C Dollery.   

Abstract

In a cross-over study, the cardiovascular effects of dobutamine were assessed in 11 patients who had undergone operation for replacement of the mitral or aortic valve approximately four hours earlier. In 9 of these the effects of isoprenaline were assessed for comparison. Dose-response curves were obtained using four dose levels of dobutamine in the range 1.25-10 mug/kg per min and of isoprenaline in the range of 0.005-0.04 mug/kg per min. Both drugs produced similar dose-dependent increases in heart rate and cardiac output and a dose-dependent decrease in peripheral resistance. Mean arterial pressure was only slightly increased by either drug. The positive inotropic effect of dobutamine was confirmed, but the chronotropic effect was not significantly different from that of isoprenaline. This contrasts with the findings of previous studies, and possible reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1275989      PMCID: PMC483045          DOI: 10.1136/hrt.38.6.622

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease.

Authors:  I Hutton; W S Hillis; C E Langhan; J M Conely; T D Lawrie
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 2.  Drug treatment of heart failure.

Authors:  C T Dollery; L Corr
Journal:  Br Heart J       Date:  1985-09

Review 3.  Inotropic drugs in acute circulatory failure.

Authors:  P Herbert; J Tinker
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

4.  Haemodynamic effects of prenalterol in patients with coronary heart disease.

Authors:  I Hutton; R G Murray; R N Boyes; A P Rae; W S Hillis
Journal:  Br Heart J       Date:  1980-02

5.  Hemodynamic effects of dobutamine in children with cardiovascular failure.

Authors:  D Schranz; H Stopfkuchen; B K Jüngst; R Clemens; P Emmrich
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

6.  [Cardiovascular effects of dobutamine (author's transl)].

Authors:  P Limbourg; H Just; F Kersting; K F Lang
Journal:  Klin Wochenschr       Date:  1978-06-01

7.  Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy.

Authors:  Desirée Luis-Rodríguez; Alberto Martínez-Castelao; José Luis Górriz; Fernando De-Álvaro; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2012-01-15

8.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

9.  Dobutamine, isoprenaline and dopamine in patients after open heart surgery.

Authors:  J H Chamberlain; J R Pepper; A K Yates
Journal:  Intensive Care Med       Date:  1980-11       Impact factor: 17.440

10.  Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction.

Authors:  T L Kho; J W Henquet; R Punt; W H Birkenhäger; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.